Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

被引:59
|
作者
Redfors, Bjorn [1 ,2 ,3 ]
Furer, Ariel [1 ,4 ,5 ]
Selker, Harry P. [6 ]
Thiele, Holger [7 ,8 ]
Patel, Manesh R. [9 ]
Chen, Shmuel [1 ,2 ]
Udelson, James E. [10 ]
Ohman, E. Magnus [9 ]
Eitel, Ingo [11 ,12 ]
Granger, Christopher B. [9 ]
Maehara, Akiko [1 ,2 ]
Kirtane, Ajay J. [1 ,2 ]
Genereux, Philippe [1 ,13 ,14 ]
Jenkins, Paul L. [15 ]
Ben-Yehuda, Ori [1 ,2 ]
Stone, Gregg W. [1 ,16 ]
机构
[1] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA
[2] Columbia Univ, Med Ctr, Dept Cardiol, NewYork Presbyterian Hosp, New York, NY USA
[3] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[4] Israel Def Forces, Med Corps, Tel Hashomer, Israel
[5] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mil Med, Jerusalem, Israel
[6] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[7] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany
[8] Leipzig Heart Inst, Leipzig, Germany
[9] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
[10] Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA
[11] Univ Heart Ctr Lubeck, Univ Hosp Schleswig Holstein, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany
[12] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Lubeck, Germany
[13] Morristown Med Ctr, Gagnon Cardiovasc Inst, Morristown, NJ USA
[14] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[15] Mary Imogene Bassett Hosp, Cooperstown, NY USA
[16] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
基金
美国国家卫生研究院;
关键词
infarct size; percutaneous coronary intervention (PCI); smoking; ST-segment elevation myocardial infarction (STEMI); ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECEIVING THROMBOLYTIC THERAPY; BOLUS ABCIXIMAB APPLICATION; SMOKERS PARADOX; CIGARETTE-SMOKING; POOLED ANALYSIS; GUSTO-I; SIZE; TRIAL;
D O I
10.1016/j.jacc.2020.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Smoking is a well-established risk factor for ST-segment elevation myocardial infarction (STEMI); however, once STEMI occurs, smoking has been associated with favorable short-term outcomes, an observation termed the "smoker's paradox." It has been postulated that smoking might exert protective effects that could reduce infarct size, a strong independent predictor of worse outcomes after STEMI. OBJECTIVES The purpose of this study was to determine the relationship among smoking, infarct size, microvascular obstruction (MVO), and adverse outcomes after STEMI. METHODS Individual patient-data were pooled from 10 randomized trials of patients with STEMI undergoing primary percutaneous coronary intervention. Infarct size was assessed at median 4 days by either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed tomography. Multivariable analysis was used to assess the relationship between smoking, infarct size, and the 1-year rates of death or heart failure (HF) hospitalization and reinfarction. RESULTS Among 2,564 patients with STEMI, 1,093 (42.6%) were recent smokers. Smokers were 10 years younger and had fewer comorbidities. Infarct size was similar in smokers and nonsmokers (adjusted difference: 0.0%; 95% confidence interval [CI]: -3.3% to 3.3%; p = 0.99). Nor was the extent of MVO different between smokers and nonsmokers. Smokers had lower crude 1-year rates of all-cause death (1.0% vs. 2.9%; p < 0.001) and death or HF hospitalization (3.3% vs. 5.1%; p = 0.009) with similar rates of reinfarction. After adjustment for age and other risk factors, smokers had a similar 1-year risk of death (adjusted hazard ratio [adjHR]: 0.92; 95% CI: 0.46 to 1.84) and higher risks of death or HF hospitalization (adjHR: 1.49; 95% CI: 1.09 to 2.02) as well as reinfarction (adjHR: 1.97; 95% CI: 1.17 to 3.33). CONCLUSIONS In the present large-scale individual patient-data pooled analysis, recent smoking was unrelated to infarct size or MVO, but was associated with a worse prognosis after primary PCI in STEMI. The smoker's paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers. (C) 2020 by the American College of Cardiology Foundation.
引用
收藏
页码:1743 / 1754
页数:12
相关论文
共 50 条
  • [41] IMPACT OF MORPHINE USE ON MORTALITY IN STEMI PATIENTS TREATED WITH PRIMARY PCI
    Hizoh, Istvan
    Domokos, Dominika
    Banhegyi, Gyongyver
    Major, Laszlo
    Edes, Istvan Ferenc
    Becker, David
    Ruzsa, Zoltan
    Merkely, Bela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 70 - 70
  • [42] TRENDS IN PCI AND OUTCOMES AMONG PATIENTS ≥ 80 YEARS OF AGE WITH STEMI
    Kolte, Dhaval
    Khera, Sahil
    Mujib, Marjan
    Palaniswamy, Chandrasekar
    Singh, Tarunjit
    Aronow, Wilbert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1883 - E1883
  • [43] In-hospital mortality prediction for STEMI patients submitted to primary PCI
    Sladojevic, M.
    Pavlovic, K.
    Velicki, L.
    Cemerlic-Adjic, N.
    Popov, T.
    Tadic, S.
    Sladojevic, S.
    Culibrk, D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 85 - 85
  • [44] The short outcomes and in-hospital complications in patients with STEMI revascularized with primary PCI: A prospective registry from India
    Singh, Ambukeshwar
    Narain, Varun
    Sharma, Jayesh
    Chaudhary, Gaurav
    Vishwakarma, Pravesh
    Yadav, Sharad
    Dwivedi, Sudhanshu
    RESEARCH IN CARDIOVASCULAR MEDICINE, 2022, 11 (04) : 96 - 101
  • [45] The obesity paradox in STEMI patients treated with primary PCI: is it a matter of sex?
    Somaschini, A.
    Crimi, G.
    Cornara, S.
    Buratti, S.
    Ferlini, M.
    Camporotondo, R.
    Gnecchi, M.
    Bartolini, D.
    Belotti, S.
    Fedele, M.
    Iannone, A.
    Beccaria, F.
    Visconti, L. Oltrona
    Rubartelli, P.
    De Ferrari, G. M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1346 - 1347
  • [46] Risk prediction in patients with STEMI undergoing primary PCI: an observational study
    Ballocca, F.
    Moretti, C.
    D'Ascenzo, F.
    Sciuto, F.
    Di Cuia, M.
    Colaci, C.
    Zoccai, G. Biondi
    Sheiban, I.
    Gaita, F.
    EUROPEAN HEART JOURNAL, 2013, 34 : 409 - 409
  • [47] SIMULTANEOUS PRESENTATIONS OF STEMI PATIENTS: HOW LONG TO WAIT FOR PRIMARY PCI?
    Chhetry, Minar
    Dai, Xuming
    Gustafson, Gregory
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 56 - 56
  • [48] The effects of nicorandil on microvascular function in patients with STEMI undergoing primary PCI
    Kostic, J.
    Dobric, M.
    Milasinovic, D.
    Dikic, A. Djordjevic
    Tesic, M.
    Stojkovic, S.
    Stepanovic, J.
    Nedeljkovic, M.
    Trifunovic, Z.
    Beleslin, B.
    EUROPEAN HEART JOURNAL, 2015, 36 : 718 - 718
  • [49] Inflammation influences late prognosis of patients with STEMI treated with primary PCI
    Pyda, M.
    Lanocha, M.
    Korybalska, K.
    Ksiazek, K.
    Grajek, S.
    Lesiak, M.
    Grygier, M.
    Katarzynska, A.
    Skorupski, W.
    Witowski, J.
    CIRCULATION, 2008, 118 (12) : E295 - E296
  • [50] The effects of nicorandil on microvascular function in patients with STEMI undergoing primary PCI
    Kostic, J.
    Milasinovic, D.
    Dobric, M.
    Dikic, A. Djordjevic
    Tesic, M.
    Stankovic, G.
    Stojkovic, S.
    Orlic, D.
    Stepanovic, J.
    Beleslin, B.
    EUROPEAN HEART JOURNAL, 2014, 35 : 645 - 646